Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

l-2 proteins, restoring cell death to cancerous cells. Additionally, the compounds were found to enhance the effects of chemotherapy and radiation used to treat other types of cancer, such as non-small cell lung cancer.

Kinase Inhibitors (ABT-869)

Many oncology researchers are currently developing agents that target kinases, a class of enzymes that are often overly activated in cancer cells. Inhibition of the appropriate kinases can suppress tumor growth by cutting off its blood supply.

Discovered by Abbott scientists, ABT-869 is an oral small molecule that provides simultaneously potent and specific inhibition of the VEGFR and PDGFR families that is in Phase I clinical trials for solid tumors and selected hematologic malignancies such as leukemia. Phase II trials for several tumor types began this year.

PARP Inhibitors (ABT-888)

DNA damaging agents remain some of the most successful treatments for cancer. The enzyme Poly(ADP-ribose)polymerase (abbreviated PARP) can help repair DNA damage caused by these agents used to treat cancer and render them ineffective. As PARP activity is often increased in cancer cells, it provides these cells with a survival mechanism.

ABT-888 is an oral PARP-inhibitor developed by Abbott researchers to prevent DNA repair in cancer cells and increase the effectiveness of common cancer therapies such as radiation and alkylating agents.

ABT-888 completed a Phase 0 trial for patients with refractory solid tumors and lymphoid malignancies, and has entered several Phase I trials. Preclinical data indicates ABT-888 has improved the effectiveness of radiation and many types of chemotherapy in animal models of cancer.

About Abbott Oncology

Abbott Oncology is committed to the discovery and development of innovative cancer treatments that enable patients to live longer and healthier lives. Abbott's oncology research is focused on developing more targeted, less toxic therapies than are cu
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Ohio (PRWEB) July 31, 2014 United ... at 9 a.m. on Monday, September 15, with its ... Methodist Church, 3440 Shroyer Rd., Kettering, OH. Dr. ... Counseling in the Emma Toussant Chair will speak on ... , Dr. Justes’ teaching and research interests include pastoral ...
(Date:7/31/2014)... July 31, 2014 In today’s world, a ... to get. Snoring and sleep apnea (a medical problem where ... and their bed partners of the rest they need to ... the population snores and 20 million people in the United ... been diagnosed and treated; and of those treated, many cannot ...
(Date:7/31/2014)... Hook Your Ex, a system created by Steve Pratt, who discovered ... their partner, to the point of starvation, that they come back ... taught to hundreds of men and women across the country with ... , Shane Michaels agrees this simple trick is genius and can ... chance at getting back together with their ex. “I was ...
(Date:7/31/2014)... NEWwoodworks, fine woodworking group at New Energy ... a website dedicated to highlighting their craft and their ... handcrafted cabinetry, furniture, stairs , doors, and other ... for taking on the remarkable, challenging projects that few ... reclaimed wood, often using near extinct species such as ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Dr. ... scientific meetings, “I love the experience of traveling and ... our centers in Southern California. We are now ... few years ago. It is our pleasure to communicate ... presentation about more efficient ways of performing FUE transplantation ...
Breaking Medicine News(10 mins):Health News:United Theological Seminary to Open 144th Year 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2
... Mich. - A cancer diagnosis affects more than just the ... Michigan Comprehensive Cancer Center finds spouses report similar physical and ... study found that what really impacted emotional distress - among ... was newly diagnosed, facing a recurrence or living with advanced ...
... Board established; Former URAC CEO joins company along with ... Chief Medical Officer, ... of key senior management leaders to head the,growing healthcare consulting and technology ... and CEO; -- Joel V. Brill, MD, AGAF FASGE FACG ...
... research that aligns patients and treatments., ... The,H. Lee Moffitt Cancer Center & ... health enterprise platform, to aid in its,development ... be used,to assimilate large quantities of diverse ...
... MEDIA, Pa., Sept. 20 Synova Healthcare Group,Inc. (OTC ... sale,of approximately $3.3 million in aggregate notional principal amount ... September 19, 2012,and related common stock purchase warrants. This ... private placement of notes and warrants in the,aggregate notional ...
... 2007 Breihan Bridgewater suffers from emphysema. He sleeps on ... it feels like theres a boulder resting on his chest. ... prostate cancer, the thought of undergoing surgery or having to ... treatments left him with an uneasy feeling and a ...
... is leading cause of inherited mental retardation , , THURSDAY, ... defect might be a target for the treatment of ... researchers report. , The discovery in rats provides an ... condition changes the way brain cells communicate, according to ...
Cached Medicine News:Health News:Cancer patients, spouses report similar emotional distress, U-M study finds 2Health News:Schooner Healthcare Services, LLC Announces New Leadership Team 2Health News:Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 3Health News:Radiation therapy technique reduces length of prostate cancer treatment 2Health News:Radiation therapy technique reduces length of prostate cancer treatment 3Health News:Brain Defect Helps Drive Fragile X Syndrome 2Health News:Brain Defect Helps Drive Fragile X Syndrome 3
(Date:7/31/2014)... , July 31, 2014 Hovione today ... has successfully passed a pre-approval inspection by the ... carried out by the FDA Consumer Safety Officer, Ms. ... on 21 st July and concluded on the 25 ... with the principles and guidelines of Good Manufacturing Practices (GMP) ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... New York results of AFF008, a ... disease. PD01A is the first therapy against the protein alpha-synuclein, ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) ... presented at the press conference on the impact a disease-modifying ...
(Date:7/31/2014)... -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused ... call on Thursday, August 14, 2014, at 4:30 p.m. Eastern ... 30, 2014. Financial results will be issued in a press ... and CEO James LaFrance will host the call, ... Thursday, August 14, 2014 Time: 4:30 p.m. Eastern time (3:30 ...
Breaking Medicine Technology:Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... BOSTON, Sept. 13 Cardiovascular disease,kills more women ... is gaining more recognition among physicians and patients, ... make diagnosis and,prognosis of women with heart disease ... What is the Optimal Method of Ischemia,Evaluation in ...
... Bionovo, Inc.,(Nasdaq: BNVI ) today announced ... for,the American Society for Pharmacology and Experimental Therapeutics, ... of,Liquiritigenin, a Bioactive Compound Isolated from the Chinese ... one of the active compounds of MF101, Bionovo,s ...
Cached Medicine Technology:What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
...
...
... Corneal biomechanical properties influence the results ... procedures, and may hold clues to ... now, assessing the biomechanical properties of ... confining practitioners and researchers to measuring ...
Inquire...
Medicine Products: